- Home
- OMEX vs COEP Comparison
OMEX vs COEP Comparison
Compare OMEX & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMEX
- COEP
- Stock Information
- Founded
- OMEX 1986
- COEP 2017
- Country
- OMEX United States
- COEP United States
- Employees
- OMEX N/A
- COEP N/A
- Industry
- OMEX Marine Transportation
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OMEX Consumer Discretionary
- COEP Health Care
- Exchange
- OMEX Nasdaq
- COEP Nasdaq
- Market Cap
- OMEX 82.2M
- COEP 86.0M
- IPO Year
- OMEX N/A
- COEP N/A
- Fundamental
- Price
- OMEX $3.63
- COEP $14.87
- Analyst Decision
- OMEX
- COEP
- Analyst Count
- OMEX 0
- COEP 0
- Target Price
- OMEX N/A
- COEP N/A
- AVG Volume (30 Days)
- OMEX 4.2M
- COEP 60.6K
- Earning Date
- OMEX 11-12-2025
- COEP 11-12-2025
- Dividend Yield
- OMEX N/A
- COEP N/A
- EPS Growth
- OMEX N/A
- COEP N/A
- EPS
- OMEX N/A
- COEP N/A
- Revenue
- OMEX $620,048.00
- COEP $263,555.00
- Revenue This Year
- OMEX N/A
- COEP N/A
- Revenue Next Year
- OMEX N/A
- COEP N/A
- P/E Ratio
- OMEX $173.68
- COEP N/A
- Revenue Growth
- OMEX N/A
- COEP N/A
- 52 Week Low
- OMEX $0.27
- COEP $2.31
- 52 Week High
- OMEX $4.43
- COEP $19.19
- Technical
- Relative Strength Index (RSI)
- OMEX 65.66
- COEP 47.73
- Support Level
- OMEX $3.13
- COEP $14.59
- Resistance Level
- OMEX $4.43
- COEP $16.17
- Average True Range (ATR)
- OMEX 0.48
- COEP 0.92
- MACD
- OMEX 0.09
- COEP -0.33
- Stochastic Oscillator
- OMEX 68.65
- COEP 11.10
About OMEX Odyssey Marine Exploration Inc.
Odyssey Marine Exploration Inc is a deep-ocean exploration company. The company provides specialized mineral exploration, project development, and marine services to clients. It is engaged in the discovery, validation, and development of subsea mineral deposits in a socially and environmentally responsible manner. The company works with governments to identify mineral resources in Exclusive Economic Zones, focusing on phosphorite (fertilizer) and polymetallic nodules (battery metals) projects. Its projects include the ExO Phosphate project, CIC, Ocean Minerals, and the LIHIR Gold project.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.